Results 41 to 50 of about 754 (158)

Non-IgE,-IgG4 Antibody to Japanese Cedar Pollen Allergens:Comparison of Its Prevalence and Titers between Pollinosis Patients and Non-Patients

Allergology International, 2005
Background: IgG antibody to allergens in the serum of pollinosis patients is not routinely measured, because there are no simple methods for assaying small amounts of specific IgG in the serum ; so far only IgE and IgG4 antibodies have been assayed.
Hiroshi Miyazawa, Masahiro Sakaguchi, Hiroshi Yasueda, Saburo Saito, Kazuya Tanaka, Kinya Nagata, Sakae Inouye   +6 more
doaj   +1 more source

Effects of Pranlukast Hydrate on Airway Hyperresponsiveness in Non-Asthmatic Patients with Japanese Cedar Pollinosis

Allergology International, 2009
Background: Recent studies have suggested that allergic rhinitis is closely related to bronchial asthma, reflecting the "one airway-one disease" hypothesis.
Hironori Sagara, Tatsuo Yukawa, Ryuichi Kashima, Takenori Okada, Takeshi Fukuda   +4 more
doaj   +1 more source

Assessing college students’ attitudes toward cedar pollinosis mitigation through artificial cedar forest reforestation in Japan

Trees, Forests and People
Cedar pollinosis is a significant public health issue in Japan, with a prevalence reaching 38.8 % in 2019. This study evaluates college students’ willingness-to-pay (WTP) for artificial cedar forest reforestation in Oita Prefecture to reduce the adverse ...
Kenta Tomizuka, Koichi Yamaura
doaj   +1 more source

Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study

Allergology International, 2015
Background: Short-term oral immunotherapy (OIT) using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis may be effective and relatively safe. However, a treatment regimen has not been established.
Daisuke Murakami, Motohiro Sawatsubashi, Sayaka Kikkawa, Masayoshi Ejima, Akira Saito, Akio Kato, Shizuo Komune   +6 more
doaj   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer, Gabriele Gadermaier, Richard E. Goodman, Alain Jacquet, Uta Jappe, Andreas L. Lopata, Anna Pomés, Monika Raulf, Keity S. Santos, Josefina Zakzuk, Yuzhu Zhang, Joana Vitte, on behalf of the WHO/IUIS Allergen Nomenclature Sub‐Committee   +12 more
wiley   +1 more source

Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients

Allergology International, 2004
Background: The aim of the present survey was to investigate the changes associated with fexofenadine administration in the quality of life (QOL) of Japanese cedar pollinosis patients.
Kimihiro Okubo, Minoru Gotoh, Kenichi Shimada, Masayo Ritsu, Makoto Kobayashi, Minoru Okuda   +5 more
doaj   +1 more source

The Effect of IPD on Japanese Cedar Pollinosis.

Practica Oto-Rhino-Laryngologica, 2001
The aim of this study was to investigate the efficacy of suplatast tosilate prescribed before the pollen season and during the pollen season. Suplatast tosilate, 300mg/day, was prescribed for 10 patients before the start of the pollen season and for 6 patients during the pollen season.
KIHARA, Noriko, ODE, Shigenori, MISU, Toshihiro, EDAMATSU, Hideo, WATANABE, Kensuke   +4 more
openaire   +1 more source

LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Background Anti‐IgE therapy can serve as an option for inadequately controlled seasonal allergic rhinitis (SAR) patients. LP‐003, a novel anti‐IgE antibody, is being tested as an add‐on treatment for SAR. This trial aimed to evaluate whether LP‐003 is effective and safe for SAR.
Kai Guan, Shuang Liu, Yan Feng, Lisha Li, Xiaoming Zhu, Nai‐Chau‐Sun Bill, Haili Ma, Jie Yang, Cuicui Han, Heng Liu, Qingyu Wei, Haiyun Shi, Xueyan Wang   +12 more
wiley   +1 more source

Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis

Allergology International, 2009
Background: Flavonoids are nutrients that exert anti-allergic effects. We investigated the preventative effect of enzymatically modified isoquercitrin (EMIQ), a flavonoid, to relieve the symptoms of Japanese cedar pollinosis. Methods: In a parallel-group,
Toru Hirano, Mari Kawai, Junsuke Arimitsu, Masako Ogawa, Yusuke Kuwahara, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Atsushi Ogata, Mihoko Koyanagi, Tomoko Kai, Ryosuke Shimizu, Masamitsu Moriwaki, Yukio Suzuki, Satoshi Ogino, Ichiro Kawase, Toshio Tanaka   +16 more
doaj   +1 more source

CLINICAL OBSERVATIONS ON JAPANESE CEDAR POLLINOSIS

Nippon Jibiinkoka Gakkai Kaiho, 1965
The existence of pollinosis in Japan has been often presumed from various points of view, but very few reports on pollinosis whose allergen is known are found so far. In 1963, in the district of Nikko and its neighbourhood, the authors hap- pened to meet 21 cases with allergic symptoms in nasal cavity, pharynx and conjunctiva, which often appear only ...
HORIGUTI, SHINSAK, SAITO, YOZO
openaire   +2 more sources